Glucosuria as a Biomarker of Adherence to Sodium-Glucose Co-Transporter Protein Type 2 Inhibitors

20260 citationsJournal Articlegold Open Access

Authors

Absent glucosuria could be an easy biomarker of poor adherence in patients treated with SGLT2i in clinical practice.

No poverty

Published in: Patient Preference and Adherence

Volume Volume 20, pp. 1-13

Field-Weighted Citation Impact: 0.00